Ocera Therapeutics (OCRX) Tops Q1 EPS by 2c

Ocera Therapeutics (NASDAQ: OCRX) reported Q1 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $31 thousand versus the consensus estimate of $270 thousand.

For earnings history and earnings-related data on Ocera Therapeutics (OCRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• SanDisk upgraded at JPMorgan after investor day; shares climb